Journals / Göztepe Tıp Dergisi / 2010 / Cilt: 25 - Sayı: 1

Bullous drug reactions

Büllöz ilaç döküntüleri

Pages
34–37
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Especially Stevens-Johnson Syndrome and toxicepidermal necrolysis may be fatal when not treated earlier.Therefore spontaneous blisters arising suddenly must drawattention to the possibility of a bullous drugreaction whichwould require early intervention.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Drug eruptions are among the most common adverse eventswhich are frequentlyassociated withantibiotics, anticonvulsants and non-steroidal antiinflammatory drugs.
📊
Key Findings & Data:Drug eruptions may be exanthematous, urticarial, blistering or pustular.Bullous drug eruptionsencompassmany differentclinicalreactions and pathomechanisms.These eruptions includefixed drug eruptions, Stevens-Johnson Syndrome, toxic epidermal necrolysis, drug-induced variants of pemphigus, bullouspemphigoid and linear IgA dermatosis, pseudoporphyria,acute generalized exanthematous pustulosis, phototoxic drugeruptions, bromoderma, iododerma and acral erythema.Bullous drug eruptions are critical since they can be lifethreatening.
💡
Conclusion & Impact:Especially Stevens-Johnson Syndrome and toxicepidermal necrolysis may be fatal when not treated earlier.Therefore spontaneous blisters arising suddenly must drawattention to the possibility of a bullous drugreaction whichwould require early intervention.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Drug eruptions are among the most common adverse eventswhich are frequentlyassociated withantibiotics, anticonvulsants and non-steroidal antiinflammatory drugs. Drug eruptions may be exanthematous, urticarial, blistering or pustular.Bullous drug eruptionsencompassmany differentclinicalreactions and pathomechanisms.These eruptions includefixed drug eruptions, Stevens-Johnson Syndrome, toxic epidermal necrolysis, drug-induced variants of pemphigus, bullouspemphigoid and linear IgA dermatosis, pseudoporphyria,acute generalized exanthematous pustulosis, phototoxic drugeruptions, bromoderma, iododerma and acral erythema.Bullous drug eruptions are critical since they can be lifethreatening. Especially Stevens-Johnson Syndrome and toxicepidermal necrolysis may be fatal when not treated earlier.Therefore spontaneous blisters arising suddenly must drawattention to the possibility of a bullous drugreaction whichwould require early intervention.

Özet

İlaçların en çok görülen yan etkilerinden biri olan ilaç döküntüleri sıklıkla antibiyotikler, antikonvülsanlar ve non-steroidantiinflamatuvar ilaçlara bağlı olarak gelişir. İlaç döküntüleriekzantamatöz, ürtikeryal, büllöz ya da püstüler olabilir. Büllözilaç döküntüleri çeşitli klinik tablolar ve mekanizmalarla oluşur. Bu döküntülerfiks ilaç erüpsiyonu, Stevens-JohnsonSendromu, toksik epidermal nekrolizis, ilaca bağlı pemfigus,ilaca bağlı büllöz pemfigoid, ilaca bağlı lineer IgA dermatozu,ilaca bağlı psödoporfirya, akut jeneralize ekzantematöz püstüloz, fototoksik ilaç reaksiyonları, bromoderma, iyoderma veakral eritemi içerir. Büllöz ilaç döküntüleri hayatı tehdit etmeleri açısından büyük önem taşır. Özellikle Stevens-JohnsonSendromu ve toksik epidermal nekrolizis zamanında müdahaleedilmediğinde fatal seyredebilir. Bu nedenle hastalarda tedavisırasında aniden ortaya çıkan büllöz lezyonlar ciddiye alınmalı ve ilaca bağlı bir reaksiyon olabileceği akılda bulundurulmalıdır.

🔖

Cite This Article

ZİNDANCI, İ., KURAL, E., KAVALA, M., GÖNCÜ, K. E. (2022). Bullous drug reactions. Göztepe Tıp Dergisi, Cilt: 25 - Sayı: 1, 34–37. https://ajindex.com/articles/651091

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Revuz J, Valeyrie-Allanore L. Drug reactions. In: Bolognia JL, Jorizzo JL, Rapini Rp, editors. Dermatology. 2nd ed. St Louis. Mosby 2008:301-320
  2. Nassif A et al. Drug spesific autotoxic T-cells in the lesions of a patient with toxic epidermal necrolysis. J Invest Dermatol 2002;118:728
  3. O Rion E, Gazit E, Brenners S. Pemphigus vulgaris possbly triggered by eilazapril. Acta Derm Venereal 2000;80:220
  4. Mascaro JM. Other vesiculobullous diseases. In: Bolognia JL, Jorizzo JL, Rapini Rp, editors. Dermatology. 2nd ed. St Louis. Mosby 2008:467- 488
  5. Pelicano R, Lomuto M, Ciavarelle G, et al. Fixed drug eruptions with leprazone are linked to HLA- 22. J Am Acad Dermatol 1997;36:782-784
  6. Fritsch PO, Elias PM. Erythema multiforme and toxic epidermal necrolysis. Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, editors.Dermatology In General Medicine. 4th ed. USA McGraw-Hill: 1993. p.585-600
  7. Ertuğrul H. Aydemir. Kontakt dermatitler ve ilaç erüpsiyonları. Andrew’s Deri Hastalıkları Klinik Dermatoloji. James WD, Berger TG, Elston DM. 1. baskı. İstanbul Medikal Yayıncılık Ltd. Şti. 2008;91-138
  8. Dietrich A, Kawakuba Y, Rzany B, et al. Low N-acetylating capacity in patients with Steven-Johnson syndrome and toxic epidermal necrolysis. Exp Dermatal 1995;4:313-316
  9. Roujeau JC, Huynth TN, Bracq C, et al. Genetic susceptibility to toxic epidermal necrolysis. Arch Dermatol 1987;123:1171
  10. Chung WH, Hung SI, Hong HS, et al. Medical genetics: a marker for Steven-Johnson syndrome. Nature 2004;428:486
  11. Brenner S, Bialy Golan A, Anhalt G. Recognition of pemphigus antigens in drug -induced pemphigus vulgaris and pemphigus foliaceus. J Am Acad Dermatol 1997;36:919-923
  12. Landau M, Brenner S. Histopathologic findings in drug-induced pemphigus. Am J Dermatopathal 1997;19:411-414
  13. Vassileva S. Drug- induced pemphigoid: bullous and eicatricial. Clin Dermatol 1998;16:379- 387
  14. Ruocco V, Sacerdoti G. Pemphigus and bullous pemphigoid due to drugs. Int I Dermatol 1991;30:307-312
  15. Geissman C, Beylot-Barry M, Doutre MS. Drug- induced linear IgA bullous dermatosis. J Am Acad Dermatol 1995;32:296
  16. James WD, Berger TG, Elston DM, editors. Errors in metabolism. Andrews’ Disease of the skin. 10 th ed. Canada: Saunders 2006, 519-546
  17. Shear NH, Knowles SR, Shapıro L. Cutaneous reactions to drugs.In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Jeffell DI, editors. Dermatology in general medicine. 7th ed. USA. Mc Graw- Hill: 20